|
US2019240284A1
|
|
Terlipressin compositions and their methods of use
|
|
WO2017127710A1
|
|
Oral octreotide for the treatment of disease
|
|
AU2016215350A1
|
|
Method of treating diseases
|
|
EP3229824A1
|
|
Oral octreotide administered in combination with other therapeutic agents
|
|
AU2015201581A1
|
|
Pharmaceutical Compositions and Related Methods of Delivery
|
|
US2016220443A1
|
|
Overlay for medication card
|
|
WO2012097155A1
|
|
Improved pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof
|
|
GB201104473D0
|
|
Improved pharmaceutical compositions and methods of delivery
|
|
BRPI0918652A2
|
|
Pharmaceutical compositions and related release methods.
|
|
WO2008117125A2
|
|
Compositions capable of facilitating penetration across a biological barrier
|
|
US2007275055A1
|
|
Compositions capable of facilitating penetration across a biological barrier
|
|
MXPA06011871A
|
|
Compositions capable of facilitating penetration across a biological barrier.
|
|
AU2004317954A1
|
|
Compositions capable of facilitating penetration across a biological barrier
|
